AbbVie (ABBV) reaches $272.42, its second consecutive 52-week high

As seen on the 24/7 Wall St. homepage on October 8, 2026.

ABBV AbbVie
New 52-week high $272.42 +0.4% vs prior high · 2026-10-07
$278$236$193

AbbVie set a fresh 52-week high at $272.42, the second straight day of records for the drugmaker. Keep an eye on whether it holds.

Continue ReadingShow less

AbbVie closed at $272.42 on October 8, 2026, a second straight record high. Back-to-back all-time highs in a large-cap pharmaceutical name make the pattern itself worth tracking.

The acceleration into these consecutive records followed a sustained period of consolidation, pointing to a broader trend gaining momentum rather than one unusual session.

Holders now face the question of whether the move has legs with no prior ceiling to reference, and anyone on the sidelines has no recent price history above $272.42 to anchor an entry.

The prior 52-week high on October 7 is now the immediate support level to watch. Holding above it keeps buyers in control, and a close below it is the first sign the breakout is stalling.

Sources

Mentioned: ABBV

Related Market Updates

ABBV AbbVie
New 52-week high $266.28 +0.1% vs prior high · 2026-08-19
$272$232$192

AbbVie cleared its August record with a fresh 52-week high at $266.28, 0.12% above the prior peak, on the same day it announced FDA approval of JUVMO. A $470.9 billion pharma making new highs is a momentum signal income investors rarely get.

Read more
HOUSE TRADE DISCLOSURE Pete Sessions
  • ABBV AbbVie Inc. Common Stock (ABBV)Sell$15K – $50KSep 14
  • GOOGL ET IRA Alphabet Inc. - Class A Common Stock (GOOGL)Sell$15K – $50KSep 14
Made public 4 days after the earliest trade

Sessions dumped a big pharma name and Alphabet on the same day, then filed within four days, an unusually fast turnaround that pins down the timing. Paired healthcare and megacap tech selling from a sitting House member is a signal to catch before the next leg of either trade.

Read more
52-week highs
6 stocks hit new 52-week highs this week
  • SSentinelOne$20.94+6.1%
  • KOCoca-Cola$91.1+2.3%
  • EXPEExpedia$321.63+1.3%
  • ABNBAirbnb$187.3+1.2%
  • ABBVAbbVie$264.96+1.0%
  • PFEPfizer$28.07+0.6%

Six names hit fresh 52-week highs this week: SentinelOne led at 6.14% above its prior peak, with Coca-Cola, Expedia, Airbnb, AbbVie and Pfizer all clearing old ceilings too.

Read more
ABBV AbbVie
New 52-week high $265.97 +1.0% vs prior high · 2026-07-29
$271$233$196

AbbVie touched a new 52-week high at $265.97, clearing its July 29 peak. The $470 billion pharma has left its spring range near $200 behind.

Read more